The Gross Margin of Lionco Pharmaceutical Group Co Ltd (603669.SS) is 42.75%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-12-31 | 42.75% |
| 2024-12-31 | 45.81% |
| 2023-12-31 | 44.50% |
| 2022-12-31 | 67.47% |
| 2021-12-31 | 79.16% |
| 2020-12-31 | 84.37% |
| 2019-12-31 | 86.28% |
| 2018-12-31 | 87.85% |
| 2017-12-31 | 80.00% |
| 2016-12-31 | 57.54% |